Chinese Herbal Medicines Might Improve the Long-Term Clinical Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: Results of a Decision-Analytic Markov Model

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left">Variables</td><td align="center" colspan="2">Probability</td></tr><tr class="thead"><td align="left">ACS after PCI</td><td align="center">CHMs plus conventional treatment</td><td align="center">Conventional treatment alone</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">Nonfatal AMI</td><td align="center">0.005 (0, 0.0119)</td><td align="center">0.0175 (0.0047, 0.0303)</td></tr><tr><td align="left">Nonfatal stroke</td><td align="center">0.0074 (0, 0.0158)</td><td align="center">0.0150 (0.0031, 0.0269)</td></tr><tr><td align="left">Nonfatal UA</td><td align="center">0.0149 (0.0031, 0.0267)</td><td align="center">0.0399 (0.0207, 0.0591)</td></tr><tr><td align="left">Death</td><td align="center">0.0050 (0, 0.0119)</td><td align="center">0.0075 (0, 0.0159)</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>ACS: acute coronary syndrome; PCI: percutaneous coronary intervention; AMI: acute myocardial infarction; CHMs: Chinese herbal medicines; UA: unstable angina.<br/></td></tr></table>

Model parameters (1-year decision-analysis model).

Evidence-Based Complementary and Alternative Medicine

tab1

Table 1

Table 1: Chinese Herbal Medicines Might Improve the Long-Term Clinical Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: Results of a Decision-Analytic Markov Model 

Table 1 | Chinese Herbal Medicines Might Improve the Long-Term Clinical Outcomes in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: Results of a Decision-Analytic Markov Model 